Concepedia

Weiguo Xiang

WX

Statistics

Publications

11

Citations

1.3K

H-Index

10

Active since

2008

Affiliations

University of Michigan(Current)

Xiamen University

Weiguo Xiang is an author at University of Michigan specializing in drug discovery, pharmacology, and androgen receptor targeting.

Publications per year

2008–2023

11

Publications

11

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer

Xin Han, Chao Wang, Chong Qin et al. · Journal of Medicinal Chemistry · 2019 · 381 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression

Chong Qin, Yang Hu, Bing Zhou et al. · Journal of Medicinal Chemistry · 2018 · 263 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands

Xin Han, Lijie Zhao, Weiguo Xiang et al. · Journal of Medicinal Chemistry · 2019 · 212 citations · Full text

Medicine, Oncology, Pharmacology +15

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Weiguo Xiang, Lijie Zhao, Xin Han et al. · Journal of Medicinal Chemistry · 2021 · 140 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Xin Han, Lijie Zhao, Weiguo Xiang et al. · Journal of Medicinal Chemistry · 2021 · 137 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 11